particular, according to the number of affected first-degree relatives (from 1.85 for one relative to 8.52 for at least three affected relatives) and the age of relatives at diagnosis (from 2.18 for relatives 50 years to 3.55 for affected relatives < 50 years).
≥
The adenoma-carcinoma sequence suggests that colorectal adenomas and cancers share common environmental and genetic risk factors. However, relatively few epidemiological studies have investigated the risk of developing colorectal neoplasia for first-degree relatives of patients with adenomas. A meta-analysis of nine studies estimated the relative risk of colorectal cancer in relatives of patients with adenomas as 1.99 (95 CI, 1.55 2.55) . Most of these studies used a similar design and compared the frequency of self-reported % -5 family history of colorectal cancer among patients with adenomas and either polyp-free controls, or spouse controls, or hospital controls.
Thus, the choice of the control group may be questionable in some of these studies. Furthermore, information on relatives was not obtained by colonoscopic screening but by interview and is possibly subject to recall biases in the reporting of family histories of colorectal cancers.
In addition, these studies could not provide an estimation of the risk of colorectal adenomas, especially high-risk adenomas, in relatives of patients with adenomas. In this targeted population, this latter point is important because the choice of the screening strategy largely depends on the magnitude of the risk of both colorectal adenomas and cancers. As a consequence, screening procedures for relatives of patients with high-risk adenomas are not as well-established as screening strategies for relatives of patients with colorectal cancer.
The GEADE study, a French study about the genetic factors of colorectal adenomas, gave us the opportunity to use an original design to compare the prevalence of colorectal neoplasia detected by endoscopy in first-degree relatives of patients with large adenomas, and in matched endoscopic control patients. Following the findings of a previous work among first-degree relatives of patients with colorectal cancer , the aim of the present study was to demonstrate and quantify the high risk of both cancers and large adenomas, in first-degree 7
relatives of patients with large adenomas.
Methods

Study subjects and data collection
The GEADE study is a case-control and family study of patients with high-risk adenomas. The primary aim was to compare the frequency of various susceptibility genes in patients with large adenomas (index cases) and in controls with small adenomas or free of adenomas . A secondary aim based on the family part of the study was to assess the compliance with colonoscopy in first-degree relatives 8
with large adenomas . 9
The study was performed in 18 participating gastroenterology units in French non-university hospitals. They were located in small to medium-sized towns throughout the country (six towns were in a large area around Paris called Greater Paris area , three in northeast ' ' France, two in the South-west, three in the South-east and four in central France). Subjects involved in the present analysis were first-degree relatives of patients with large colorectal adenomas. From September 1995 to March 2000, 306 consecutive patients with a newly-diagnosed adenoma 10mm were enrolled and referred as index cases. Index cases had no previous history of colorectal cancer or ≥ other cancer, familial adenomatous polyposis syndrome, established hereditary non-polyposis colorectal cancer and inflammatory bowel diseases. As indicated in , 267 patients out of 306 consented to provide information on their family during a face-to-face interview Figure 1 with participating gastroenterologists. Family data included information on all first-degree relatives (parents, siblings and offspring), i.e. demographic and medical characteristics such as name, date of birth and/or age, residence area, vital status, cause and age at death if applicable, history of polyps or cancer. In accordance with French ethical rules, relatives of the patients were not directly contacted by the investigators. During a special consultation, the study was explained to the index cases who were asked to contact their relatives and to pass on an explanatory booklet. The booklet contained an explanatory letter describing the aims of the study and its implementation, general information about colorectal cancer, an informed consent sheet showing the advantages and potential drawbacks of colonoscopy and a health study questionnaire. Information about the genetic part of the study was given, together with a specific informed consent form, tubes for blood sampling and a letter for the customary laboratory used by the relative. Unless they had undergone a colonoscopy during the five preceding years, relatives aged 40 75 were asked to have a colonoscopy with the gastroenterologist of their choice including gastroenterologists practising outside study centres.
Among 1763 first-degree relatives identified, 674 were alive, aged 40 75 and could be contacted by the index case. One hundred and seventy relatives from 97 families underwent a colonoscopy. Among them, 56 relatives had been examined over the five preceding years, and 114 underwent a screening colonoscopy resulting in an overall proportion of subjects with colonoscopy of 25 . Reports of % 9 endoscopic and, if applicable, histological examinations were obtained for all but 10 relatives, of which eight declared that no lesion was discovered during their colonoscopy and two did not know the results of the colonoscopy. These last two subjects were excluded from the present study. Thus, the case group was composed of 168 first-degree relatives. The colonoscopy was complete in 134 first-degree relatives (79.8 ), reached the ascending colon in two relatives, whereas no information about the level of colonoscopy was obtained for 32 % relatives.
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Statistical analysis
The study design was based on the results of our previous work among first-degree relatives of patients with colorectal cancer . A 7 priori calculations of the sample size were as follows: assuming about 2.5 relatives per index case who would be contacted and a participation rate of 30 among relatives, the recruitment of 252 index cases provided a statistical power of 80 to detect an odds ratio % % (OR) of 2.5 associated with a high risk of both cancers and large adenomas, with 2 controls per case and a prevalence of cancers/large adenomas of 4 in controls (unilateral test). For added security, we extended the recruitment of index cases to 306. % A logistic regression analysis was used to compare the prevalence of lesions between relatives and control subjects, and results were expressed as odds ratios (OR) and 95 CI. Both conditional and unconditional logistic regressions, adjusted for matching variables (age, % geographical area and sex), were performed. Because they yielded very close results, we have chosen to show results from the unconditional logistic regression only for sake of simplicity. In these analyses, the most severe colonoscopic finding was introduced as an independent variable in several ways. It was considered as a dichotomous variable (cancer or adenomas no colorectal neoplasia), a versus four-class categorical variable (cancer large adenomas small adenomas no colorectal neoplasia), or a three-class versus versus versus categorical variable (cancer or large adenomas small adenomas no colorectal neoplasia). In addition, stratified logistic versus versus regression analyses were carried out according to characteristics of the index case at diagnosis. Given that there may be some degree of correlation between relatives of the same family, main data were reanalyzed by keeping only one relative per family (n 96) and matched = controls (n 174). The analysis included all relatives from families with a single member and one randomly selected relative from each = family with 2 or more members. All statistical analyses were performed using SAS software (version 9.1; SAS Institute, Cary, North Carolina, USA).
Results
The median age of first-degree relatives and controls was 53 years and 57 years, respectively. Among the 168 first-degree relatives, there were 12 parents (7.1 ) of the index case, 104 siblings (61.9 ) and 52 children (31.0 ). The median age was 66 years for the parents % % % (range 52 74), 61 years for the siblings (range 42 73) and 46 years for the children (range 40 59). As shown in , there were no --- Table 1 significant differences between relatives and controls regarding age, gender and geographical area.
Colonoscopic findings among first-degree relatives and controls are shown in . Five cancers were observed in relatives (one Table 2 TNM stage I, one stage II, one stage IV and two cancers with unknown stage) and 3 cancers in controls (one stage I and two stage III cancers). With these new observations in first-degree relatives, one family was found to meet Amsterdam criteria (three affected members from two generations, of whom one was under 50 at the diagnosis of colorectal cancer). Among subjects free of colorectal cancer, 33 relatives and 47 controls presented at least one adenoma. Prevalence of adenomas was higher in men than in women in both relatives (24.0 16.1 ) and controls (17.3 versus 14.9 ). The prevalence of adenomas also increased with age in both relatives and controls. It % versus
The risk associated with one first-degree relative affected by large adenomas depended on the severity of neoplasia ( ). For Table 2 large adenomas and cancers considered together, the 0R was 2.27 (95 CI, 1.01 5.09). It was 1.21 for small adenoma (95 CI, 0.68 As indicated in , certain characteristics of the index case affected the prevalence of colorectal neoplasia in relatives. The risk of Table 3 finding large adenomas or cancers in first-degree relatives was higher when their index case was under 60 (OR 3.82; 95 CI, 0. This study had an original design and, to our knowledge, was the first to prospectively ask first-degree relatives of patients with large colorectal adenomas to undergo a colonoscopy, and to compare endoscopic findings to those observed in a control population. This contrasts with previous studies which compared frequency of a family history of colorectal cancer among patients with newly diagnosed adenomas, with that among control . In these studies, the choice of controls such as spouses or hospital controls is questionable and 12-17 may lead to an underestimation of the association with family history. Furthermore, they do not allow for any assessment of the risk of adenoma in relatives. Indeed, first-degree relatives may had never undergone a colonoscopy and, even if this had been the case, the study subjects could have been unaware of the endoscopic findings in their relatives. Furthermore, these retrospective studies may be subject to recall biases, because patients with adenomas are more likely than control patients to remember a family history of colorectal cancer.
Lastly, in most previous studies, no attempt had been made to validate a self-reported family history of colorectal cancer, by direct interview of relatives or by review of medical records.
The present study also presented several limitations, suggesting however that our risk estimates were rather conservative. Because of recruitment procedures of relatives of patients with large adenomas, the ideal design could have been to offer a colonoscopy to first-degree relatives of polyp-free patients. Such a design was impossible for ethical and statutory considerations and we chose to include as controls, consecutive patients who had had a colonoscopy for minor symptoms and did not report any family history of colorectal cancer or adenoma. Our choice was guided by several considerations. First, first-degree relatives were generally asymptomatic, and it was preferable to have a control group as close as possible to this population. Second, the exclusion of patients with a family history of colorectal cancer had the advantage of discarding some patients with an unknown family history of colorectal adenomas, a feature probably common in the general population. Although this strategy could theoretically lead to an over-estimation of the differences in prevalence of neoplasia between cases and controls, it appeared to be the most appropriate because the family history of colorectal cancer was the sole indication or one of the indications for colonoscopy in 92 of these patients. Despite these precautions, a history of large adenomas in first-degree % relatives was probably unknown to certain controls, which in turn led to an under-estimation of the association with the risk of colorectal neoplasia. Another limitation was linked to the small proportion of first-degree relatives who agreed to participate in the study and underwent a colonoscopy. It is uncertain whether the participating first-degree relatives were truly representative of the 674 eligible first-degree relatives or of all 1763 living and deceased first-degree relatives. However, we showed in previous research that the compliance of relatives with colonoscopy was only marginally influenced by the characteristics of both relatives and index cases , so that 9 it is unlikely that major selection biases may have affected our study sample. The main determinants of compliance with colonoscopy for first-degree relatives were their young age and place of residence outside of Greater Paris area (both used as matching variables in the inserm-00359900, version 1 -9 Feb 2009 Adenomas in relatives and colorectal tumor risk Gastroenterology. Author manuscript Page / 5 9 present analysis), whereas family history of colorectal cancer had no significant influence on participation rate. Usually, subjects who participate in screening programs are healthier than non participants. Thus, the observed frequency of colorectal neoplasia in relatives may be lower than the actual frequency, possibly resulting in an underestimation of the differences with controls. Another limitation was due to the lack of information about completeness of colonoscopy could be ascertained in 20 of relatives, generally examined outside study % centres. Thus, if the colonoscopy was incomplete in some of these subjects, we cannot exclude attenuation in the relative risk of colorectal neoplasia. Lastly, because of the low participation rate of first-degree relatives, this is a relatively small-sized study with a statistical power of only 75 to detect an OR of 2.5 associated with the risk of both cancers/large adenomas and a limited power to detect weaker % associations between a family history of large adenomas and the risk of colorectal neoplasia.
Despite these limitations, the findings of the present study showed striking similarities with those obtained in a previous French study, which used a comparable design for first-degree relatives of patients with colorectal cancer . In this previous study as in the present one, 7
no association was found with the risk of small adenomas (odds ratio of 1.2) whereas the risk of large adenomas was significantly increased by 2.5 in subjects with a family history of colorectal cancer. Eight of the nine studies included in a recent review also found an increased risk for first-degree relatives of colorectal cancer associated with adenoma, with a summary estimate of familial risk at 1.99 . 5
Only one of these studies examined the risk of colorectal cancer for first-degree relatives according to the size of adenomas in index cases . The comparison of several groups of adenoma patients and polyp-free controls revealed that the relative risk of colorectal cancer for 13 first-degree relatives was higher in relatives of patients with large adenomas than in those with small adenomas (odds ratios of 2.1 and 1.2, respectively). These findings were partially confirmed by a recent study, which showed only a modest and non-significant increase in the risk of colorectal cancer in relatives of patients with small tubular adenomas (odds ratio of 1.26), and a significant increase in relatives of patients with advanced adenomas, i.e. adenomas larger than 10 mm and/or with villous component or high-grade dysplasia (odds ratio of 1.62) . Thus, despite some variations among studies in the magnitude of familial risk due to differences in study design and populations 14 studied, there now appears to be strong evidence that first-degree relatives of patients with large adenomas are at high risk of developing colorectal neoplasia, whereas it is probably not the case for relatives of patients with small adenomas. This is consistent with epidemiological knowledge about adenomas. Adenomas are very common in the general population as indicated by autopsy studies , . 16 17
In a French autopsy study, overall adenoma prevalence was around 28 , increasing from 16 in the under-64 age group to 33 in the 65 % % % -74 age group and 46 in the over-74 age group (personal data). If all individuals with a history of adenoma in their first-degree relatives % were at high risk of colorectal neoplasia, the incidence of colorectal cancer in the general population would probably be higher than it is.
There are some indications that the risk of colorectal neoplasia in relatives might depend on the characteristics of the affected family member. Indeed, this study showed an increased risk of neoplasia, especially of large adenomas and cancers, when the index case was male and younger than 60 years. A link between a younger age at adenoma diagnosis and familial risk of colorectal cancer has previously been reported in a number of studies , , but not in one study , possibly due to a narrower age range concerning adenoma patients. 10 13 15 14 Furthermore, our study suggested that first-degree relatives of patients with a large distal adenoma could be more prone to develop colorectal neoplasia, especially distal large adenomas and cancers, than relatives of patients with proximal adenomas. Also in the study of Lynch et al. , the prevalence of family history of colorectal cancer was slightly higher in patients with distal adenomas than in patients 14 with proximal adenomas. In addition, our previous work performed with a similar design among first-degree relatives of patients with colorectal cancer also revealed an influence of cancer location . In this latter study, relatives of patients with distal cancer were more 7 likely to present high-risk adenomas than relatives of patients with proximal cancer. As in the present study, adenomas were more likely to be located on the left colon when the cancer site was the left colon. Thus, although no firm conclusions could be drawn from existing data, these may suggest some degree of resemblance in tumoral site among family members. This hypothesis needs to be more thoroughly investigated in future studies using appropriate design and sample size.
Thus, there is now evidence that first-degree relatives of patients with large adenomas may need to be screened and monitored as carefully as relatives of patients with colorectal cancer. This may be especially true for relatives when the index case is younger than 60 years, male and had large adenomas in the left colorectum. However, screening recommendations for relatives of patients with large adenomas raise some issues. At the individual level, colonoscopy would probably be the most appropriate screening method in these high- first-degree relatives older than 60 years diagnosed with colorectal cancer because of the small increase in risk. Likewise, American guidelines recommend colonoscopy at 40 years, or 10 years before the index case, for individuals with a strong family history of colorectal cancer or polyps , . However, from a public health point of view, there is no evidence that such screening strategies may be the most 19 20 cost-effective if the acceptability of colonoscopy in first-degree relatives of patients with large adenomas is as low as in our study (around 20 ). Furthermore, our previous analyses showed a strong intra-familial correlation of colonoscopic screening acceptance, indicating that % a large proportion of families would be completely excluded from screening (around 40 ) . Appropriate strategies need to be developed % 9 
